Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts February 01, 2019 Table of Contents (TOC)

Transcription

1 Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts February 01, 2019 Table of Contents (TOC) Notices Notice of OBSSR Participation in NOT DA "HEAL Initiative: Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630)" (NOT OD ) Office of Behavioral and Social Science Research Notice of Participation of the Office of Research on Womens Health (ORWH) in RFA HG , Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed) (NOT OD ) Notice of Information: Report on Site Visits to the Veterans Affairs Medical Centers with Focus on Canine Care and Use in Research (NOT OD ) National Institutes of Health Notice of Special Interest on Methodological Advances to Improve Alcohol Measurement and its Consequences for People Living with HIV who have Comorbidities, Coinfections, and Complications (NOT AA ) National Institute on Alcohol Abuse and Alcoholism Request for Information (RFI): Inviting Comments and Suggestions on NIAIDs Antibacterial Resistance Research Framework (NOT AI ) Notice of NIAID Research Objectives added to PAR Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) (NOT AI ) Notice of NIAID Research Objectives added to PAR Academic Research Enhancement Award for Undergraduate Focused Institutions (R15 Clinical Trial Not Allowed) (NOT AI ) Pre Solicitation Notice: NIAID Clinical Research Products Management Center (NOT AI )

2 Notice of NCCIH's Participation in PA , "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)" (NOT AT ) National Center for Complementary and Integrative Health Notice of Request for Information to Better Facilitate Cancer Systems Epidemiology Research (NOT CA ) Notice for a Pre application Webinar for Funding Opportunity Announcement PAR "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)" (NOT CA ) Notice of Change to Award Information in RFA CA "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)" (NOT CA ) Notice to Clarify NIBIB's Research Objectives Under PAR , "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)" (NOT EB ) National Institute of Biomedical Imaging and Bioengineering Notice of NHLBI Participation in RFA TR "HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)" (NOT HL ) National Heart, Lung, and Blood Institute Notice of Intent to Publish Funding Opportunity Announcement to Improve Care Transitions Through the Use of Interoperable Health Information Technology (R01) (NOT HS ) Agency for Healthcare Research and Quality Notice to Extend PA (NOT HS ) Agency for Healthcare Research and Quality Notice of Additional Receipt Date for PAR "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)" (NOT MD ) National Institute on Minority Health and Health Disparities National Institute of Biomedical Imaging and Bioengineering National Library of Medicine Office of Behavioral and Social Science Research Notice of Correction to PA , Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)

3 (NOT MH ) Notice of Change to PAR Clinical and Translational Science Award (U54 Clinical Trial Optional) (NOT TR ) National Center for Advancing Translational Sciences Notice of Information: NCATS Clinical and Translational Science Awards (CTSA) Interest in Improving Rural Health Outcomes and Eliminating Health Disparities (NOT TR ) National Center for Advancing Translational Sciences Notice of Clarification in Eligibility Requirements for PAR Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) and PAR Emerging Global Leader Award (K43 Independent Clinical Trial Required) (NOT TW ) John E. Fogarty International Center Requests for Applications Computational Models of Immunity (U01 Clinical Trial Not Allowed) (RFA AI ) Application Receipt Date(s): June 10, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed) (RFA CA ) Application Receipt Date(s): April 1, 2019, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed) (RFA CA ) Application Receipt Date(s): April 1, 2019, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) (RFA DK )

4 Application Receipt Date(s): April 10, 2019 and November 20, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (U01 Clinical Trial Required) (RFA DK ) Application Receipt Date(s): April 10, 2019, by 5:00 PM local time of applicant organization. Applicants are Data Coordinating Center for the Advanced Clinical Trials Consortium to Test Artificial Pancreas Device Systems (U24 Clinical Trial Not Allowed) (RFA DK ) Application Receipt Date(s): April 10, 2019 by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity are due on this date. Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional) (RFA DK ) Application Receipt Date(s): April 24, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the Developmental Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Not Allowed) (RFA DK ) Application Receipt Date(s): April 10, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) (RFA DK ) Application Receipt Date(s): April 24, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed) (RFA FD )

5 Food and Drug Administration Application Receipt Date(s): April 4, 2019 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on time submission means that an application is submitted error free (of both Grants.gov and era Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. Patient Reported Outcomes Tool Development for Use in Non Cystic Fibrosis Bronchiectasis Clinical Trials (U01) Clinical Trial Optional (RFA FD ) Food and Drug Administration Application Receipt Date(s): April 4, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on time submission means that an application is submitted error free (of both Grants.gov and era Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed) (RFA HG ) National Human Genome Research Institute Application Receipt Date(s): April 2, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed) (RFA HG ) National Human Genome Research Institute Application Receipt Date(s): April 2, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement Applicants are Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed) (RFA HG ) National Human Genome Research Institute Application Receipt Date(s): April 2, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) (RFA HS ) Agency for Healthcare Research and Quality Application Receipt Date(s): March 25, 2019, by 5:00 PM local time of applicant organization.

6 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional) (RFA MH ) Office of Behavioral and Social Science Research Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below. Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional) (RFA MH ) Office of Behavioral and Social Science Research Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below. Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional) (RFA MH ) Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below. Human Three Dimensional Cell Model Systems for Alzheimers Disease Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) (RFA NS ) National Institute of Neurological Disorders and Stroke National Center for Advancing Translational Sciences National Institute on Aging Application Receipt Date(s): March 14, 2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on this date.?applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the Program Announcements Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed) (PA ) Application Receipt Date(s): March 1, 2018, by 5:00 PM local time of applicant organization. Applicants are

7 Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) (PAR ) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): New applications: March 29, 2019; June 18, 2019; October 18, 2019; February 19, 2020; June 18, 2020; October 14, 2020; February 18, 2021; June 18, 2021; October 14, 2021, by 5:00 PM local time of applicant organization. Resubmission or, Revision applications: April 30, 2019; July 18, 2019; November 14, 2019; March 18, 2020; July 14, 2020; November 18, 2020, March 18, 2021; July 14, 2021; November 18, 2021, by 5:00 PM local time of applicant organization. Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) (PAR ) National Institute of Dental and Craniofacial Research National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on these dates. Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) (PAR ) National Institute of Dental and Craniofacial Research National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on these dates. Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) (PAR ) Application Receipt Date(s): May 1, 2019, September 1,2019, by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the Methods Development for Cryogenic or Other Long term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed) (PAR ) National Institute of General Medical Sciences Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. High End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) (PAR ) National Institute of General Medical Sciences

8 Application Receipt Date(s): May 31, 2019, by 5:00 PM local time at the applicant organization. All types of applications allowed for this funding opportunity are due on this date. Applicants are Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed) (PAR ) Application Receipt Date(s): May 31, 2019, by 5:00 PM local time at the applicant organization. All types of applications allowed for this funding opportunity are due on this date. Applicants are Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) (PAR ) National Institute of General Medical Sciences Application Receipt Date(s): May 31, 2019, by 5:00 PM local time at the applicant organization. All types of applications allowed for this funding opportunity are due on this date. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * You have received this information as a result of being subscribed to the UTHSCSA Office of Sponsored fundinginfo2 ListServ. To remove yourself from this list, visit the Subscriber's Corner in the List Archives and follow the onscreen instructions to log in and manage your list subscriptions. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *